ALX Oncology Holdings
ALXO · NASDAQ
$1.24+$0.10 (+8.77%)TodayMarket closed ·
Prev close $1.14
Who owns ALXO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 57.7% of ALXO’s shares.
- RA Capital Management, LP9.7%
- VenBio Partners LLC9.6%
- HBM Partners AG6.4%
- Redmile Group, LLC5.5%
- Next 6 largest institutions26.6%
- All other shareholders42.3%
| Holder | Shares | % of shares |
|---|---|---|
| RA Capital Management, LP | 13.01M | 9.67% |
| VenBio Partners LLC | 12.88M | 9.58% |
| HBM Partners AG | 8.59M | 6.38% |
| Redmile Group, LLC | 7.39M | 5.49% |
| BlackRock Institutional Trust Company, N.A. | 6.77M | 5.03% |
| Blackstone Alternative Asset Management, L.P. | 6.59M | 4.90% |
| Driehaus Capital Management, LLC | 6.03M | 4.48% |
| SilverArc Capital Management, LLC | 5.74M | 4.27% |
| TCG Crossover Management, LLC | 5.66M | 4.20% |
| Vanguard Capital Management, LLC | 4.97M | 3.70% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.64M | 2.71% |
| iShares Russell 2000 ETF | 2.59M | 1.92% |
| Vanguard Extended Market Index Fund | 1.23M | 0.91% |
| Fidelity Small Cap Index Fund | 1.17M | 0.87% |
| iShares Russell 2000 Growth ETF | 1.02M | 0.76% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $8.27K (3 trades) of ALXO on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Wong Shelly | Sale | 573 | $1.11K |
| Lettmann Jason | Sale | 2.23K | $4.30K |
| Wong Shelly | Sale | 1.40K | $2.86K |
Short interest
Settled Sep 30, 2026
- Shares short
- 5.67M
- Days to cover
- 3.79
- % of shares outstanding
- 4.22%
- Average daily volume
- 1.50M
- Change since last report
- −9.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.